LCD L35132: Home Health Plans of Care: Monitoring Glucose Control in the Medicare Home Health Population with Type II Diabetes Mellitus — Palmetto GBA
Home Health
Government source· CMS / MACverify ↗HCPCS Level II code
—
No national Medicare fee schedule we hold prices G2066. CMS fee schedules ↗
Code definition
Code
G2066
Code system
HCPCS Level II
Full description
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results
CLV Intelligence is tracking 1 policy change that cite HCPCS G2066 most recently on 2026-09-12, drawn from 1 LCD/NCD coverage update. The changes span Home Health.
Counts reflect the source documents CLV has matched to HCPCS G2066 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to G2066
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Home Health
Government source· CMS / MACverify ↗Audit documentation
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get alerts when policy changes affect G2066
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy